Stocks
Moderna (MRNA) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -266.7% | 76.3% | 51.5% | 50.7% | -47.9% | -43.6% | ||
| Changes by years, y/y, % | +805pp | +343pp | -25pp | -1pp | -99pp | -32.3% | |||
Moderna. EBITDA margin, %
Moderna. EBITDA margin, changes, pp
Moderna (MRNA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -92.8% | 7.39% | -672.5% | -511.2% | -3.76% | -43.6% | |
| Changes by years, y/y, % | -134pp | -24pp | -657pp | +5pp | +89pp | |||
| Changes by quarters, q/q, % | +17pp | +100pp | -680pp | +161pp | +507pp | |||
